Technical Analysis for RGC - Regencell Bioscience Holdings Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 5.65 | -0.88% | -0.05 |
RGC closed down 0.88 percent on Thursday, November 21, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -0.88% | |
| Fell Below 200 DMA | Bearish | -0.88% | |
| Fell Below 50 DMA | Bearish | -0.88% |
| Alert | Time |
|---|---|
| 200 DMA Resistance | about 4 hours ago |
| Up 5% | about 4 hours ago |
| Possible NR7 | about 4 hours ago |
| 50 DMA Resistance | about 6 hours ago |
| Bearish 180 Entry | about 6 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Regencell Bioscience Holdings Limited operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Learning Disabilities Autism Causeway Bay Neurocognition
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Learning Disabilities Autism Causeway Bay Neurocognition
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 32.44 |
| 52 Week Low | 3.03 |
| Average Volume | 128,353 |
| 200-Day Moving Average | 5.97 |
| 50-Day Moving Average | 5.91 |
| 20-Day Moving Average | 6.60 |
| 10-Day Moving Average | 6.23 |
| Average True Range | 1.12 |
| RSI (14) | 44.13 |
| ADX | 47.3 |
| +DI | 28.49 |
| -DI | 10.84 |
| Chandelier Exit (Long, 3 ATRs) | 9.13 |
| Chandelier Exit (Short, 3 ATRs) | 7.95 |
| Upper Bollinger Bands | 8.26 |
| Lower Bollinger Band | 4.94 |
| Percent B (%b) | 0.21 |
| BandWidth | 50.30 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.14 |
| MACD Histogram | -0.1416 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.37 | ||||
| Resistance 3 (R3) | 6.44 | 6.26 | 6.25 | ||
| Resistance 2 (R2) | 6.26 | 6.08 | 6.23 | 6.21 | |
| Resistance 1 (R1) | 5.96 | 5.96 | 5.87 | 5.89 | 6.17 |
| Pivot Point | 5.78 | 5.78 | 5.73 | 5.75 | 5.78 |
| Support 1 (S1) | 5.47 | 5.59 | 5.38 | 5.41 | 5.13 |
| Support 2 (S2) | 5.29 | 5.48 | 5.26 | 5.09 | |
| Support 3 (S3) | 4.99 | 5.29 | 5.05 | ||
| Support 4 (S4) | 4.93 |
